Neshanic, NJ, United States of America

Robert T Hrubiec


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Meriden, CT (US) (1989)
  • Neshanic, NJ (US) (1990)

Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Robert T. Hrubiec

Introduction

Robert T. Hrubiec is an accomplished inventor based in Neshanic, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds with antineoplastic activity. His work has implications for cancer treatment, showcasing the potential of innovative chemical agents in medical applications.

Latest Patents

Hrubiec holds 2 patents that focus on novel chemical compounds. His latest patents include 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenylhydrazines, which are designed to act as alkylating agents with antineoplastic properties. These compounds are characterized by specific formulas where R1 represents various alkyl and aromatic groups. They have been found effective in inhibiting tumor growth, highlighting their potential in cancer therapy. Additionally, he has developed novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines, which share similar properties and applications.

Career Highlights

Hrubiec is affiliated with Yale University, where he continues to engage in research and development of innovative chemical compounds. His work is recognized for its potential impact on cancer treatment, making him a notable figure in the field of medicinal chemistry.

Collaborations

Throughout his career, Hrubiec has collaborated with esteemed colleagues such as Alan C. Sartorelli and Krishnamurthy Shyam. These collaborations have furthered research efforts and contributed to advancements in the development of therapeutic agents.

Conclusion

Robert T. Hrubiec's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing medical science. His work in developing compounds with antineoplastic activity is paving the way for new cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…